Boston Scientific Corporation · Class II · Cleared Dec 29, 2022
| K-number | K223592 |
| Device name | Advanix Pancreatic Stent and NaviFlex Rapid Exchange (RX) Pancreatic Delivery System and Pushers |
| Applicant | Boston Scientific Corporation |
| Product code | FGE |
| Device class | Class II |
| Decision date | Dec 29, 2022 |
| Decision | Substantially Equivalent |
| Regulation | 876.5010 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov